ArticleACS omega2025
Comprehensive Proteomics Profiling Reveals Biomarkers of Oxidative Stress and Membrane Integrity in Red Blood Cells in Acute Altitude Sickness.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biomarkers and potential subtypes of acute mountain sickness: A state-of-the-science review.Redox biology · 2026Review
- Erythrocytes as immunomodulators in trauma: orchestrating clearance pathways, inflammation, and organ injury.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Red blood cells (RBCs) are vital for oxygen transport and play a key role in acute mountain sickness (AMS). Phosphorylation is one of the most rapid post-translational modifications in response to environmental changes. However, the relationship between the changes of phosphoproteins in the RBC membrane and AMS has not received much attention. We conducted proteomic and phosphoproteomic profiling of RBC (including reticulocytes and mature erythrocytes) membranes from AMS and non-AMS individuals, identifying 2383 proteins, 1076 phosphoproteins, and 2913 phosphopeptides. Specifically, AMS caused significant content changes in the proteins and phosphorylation events of the tricarboxylic acid cycle, cytoskeleton, and peroxisome. We further determined the membrane proteins and phosphopeptides related to the severity of AMS. Experimentally, RBCs in AMS exhibited excessive oxidative stress and disruption of membrane integrity. Furthermore, functional enrichment and kinase prediction analysis indicated that the kinase activities of SRC and PRKCG were significantly elevated in AMS and that these two kinases were involved in various processes of RBC injury. Mechanically, we found that inhibition of SRC and PRKCG kinase activity alleviated the destruction of the RBC integrity caused by hypoxia. This study revealed characteristic protein and phosphoprotein changes in the RBC membrane of AMS patients, which provided a valuable resource for drug development against AMS.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.